Neo Ivy Capital Management Charles River Laboratories International, Inc. Transaction History
Neo Ivy Capital Management
- $497 Million
- Q4 2024
A detailed history of Neo Ivy Capital Management transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Neo Ivy Capital Management holds 1,956 shares of CRL stock, worth $207,433. This represents 0.07% of its overall portfolio holdings.
Number of Shares
1,956
Previous 4,902
60.1%
Holding current value
$207,433
Previous $965,000
62.59%
% of portfolio
0.07%
Previous 0.33%
Shares
4 transactions
Others Institutions Holding CRL
# of Institutions
703Shares Held
50.8MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.16MShares$653 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$540 Million0.02% of portfolio
-
State Street Corp Boston, MA2.18MShares$231 Million0.02% of portfolio
-
Allspring Global Investments Holdings, LLC1.81MShares$192 Million0.56% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.81MShares$191 Million0.79% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $5.39B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...